Skip to content

Lifecore Biomedical, Inc. LFCR Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$146.09M-2.8%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$25.12M-1.8%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$9.16M+157%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$113.4M+12.7%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$12.98M+46.7%
Danaher logo
DanaherDHR
$1.2B+9.1%

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s operating lease liabilities (total)?
Lifecore Biomedical, Inc. (LFCR) reported operating lease liabilities (total) of $1.4M in Q1 2026.
How has Lifecore Biomedical, Inc.'s operating lease liabilities (total) changed year-over-year?
Lifecore Biomedical, Inc.'s operating lease liabilities (total) decreased by 19.1% year-over-year, from $1.73M to $1.4M.
What is the long-term trend for Lifecore Biomedical, Inc.'s operating lease liabilities (total)?
Over 5 years (2021 to 2026), Lifecore Biomedical, Inc.'s operating lease liabilities (total) has grown at a -43.4% compound annual growth rate (CAGR), from $24.07M to $1.4M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.